Translational projects to improve soft tissue sarcoma diagnosis and treatment
Developmental Research Program
['FUNDING_OTHER'] · SLOAN-KETTERING INST CAN RESEARCH · NIH-11181626
This program funds small projects that use discoveries from animal and human sarcoma biology to develop better tests and treatments for people with soft tissue sarcoma.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SLOAN-KETTERING INST CAN RESEARCH (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11181626 on ClinicalTrials.gov |
What this research studies
The program at Memorial Sloan Kettering provides seed funding to quickly advance innovative translational projects focused on soft tissue sarcoma. Projects may use animal models, human tumor samples, and clinical data to create and test new diagnostic tools, prognostic markers, and treatment approaches. The program intends to support at least two awards per year using institutional, philanthropic, and SPORE funds to move promising ideas forward. Funded projects are chosen for creativity and potential to link laboratory findings to clinical use or clinical trials.
Who could benefit from this research
Good fit: People with soft tissue sarcoma, particularly those treated at or willing to travel to MSK and interested in clinical studies or donating tissue samples, are the best fit for participation.
Not a fit: People without soft tissue sarcoma or those unable to access participating centers are unlikely to directly benefit from this program's projects.
Why it matters
Potential benefit: If successful, these projects could lead to earlier diagnosis, better prediction of outcomes, and more effective treatments for people with soft tissue sarcoma.
How similar studies have performed: Some prior translational sarcoma projects have yielded useful biomarkers and informed new therapies, but many proposals supported here will still be experimental.
Where this research is happening
NEW YORK, UNITED STATES
- SLOAN-KETTERING INST CAN RESEARCH — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LADANYI, MARC — SLOAN-KETTERING INST CAN RESEARCH
- Study coordinator: LADANYI, MARC
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.